13 July 2016 - U.S. drug spending is far higher than commonly believed.
Last month, House Speaker Paul Ryan unveiled the GOP’s comprehensive plan for health reform. It included 30-odd pages of constructive proposals for replacing Obamacare, reforming entitlements, and promoting innovation. But the plan was also notable for what it didn’t contain: a clear plan to tackle the high and rising price of branded prescription drugs.